DVA DaVita Inc. Common Stock
NYSE · Health Care · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 4, 2026
$178.69
· % 处于52周区间
· 高于低点
· 至高点
$101.0052周低点
$247.4952周高点
市值 (MRQ)
$11.43B
P/E (TTM)
14.7
EPS (TTM)
$12.15
收入 (TTM)
$14.01B
DVA 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$178.69
市值 (MRQ)
$11.43B
P/E (TTM)
14.7
EPS (TTM)
$12.15
收入 (TTM)
$14.01B
股息收益率
0.00%
ROE (TTM)
-149.4%
52周区间
$101–$247
DVA 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
股票拆分
| 除息日 | 拆股 | 类型 |
|---|---|---|
| 2013年9月9日 | 2-for-1 | 正向 |
| 2004年6月16日 | 3-for-2 | 正向 |
| 1997年10月21日 | 5-for-3 | 正向 |
关于 DaVita Inc. Common Stock 公司概况（来自维基百科）
DaVita Inc. (a shortened contraction of "dare vita, meaning "to give life" in the Italian language) is an American health care company, incorporated in Delaware and headquartered in Denver, that provides kidney dialysis services through a network of 2,657 outpatient centers in the United States. DaVita serves 200,500 patients (36% of the total of 557,000 patients in the U.S.), and has 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the 2026 Fortune 500.
## History
The company was founded in 1979 as Medical Ambulatory Care, Inc., a subsidiary of National Medical Enterprises, Inc. (now Tenet Healthcare).
In August 1994, 70% of the company was acquired by DLJ Merchant Banking Partners in a leveraged buyout for $75.5 million, including a $10.5 million investment by DLJ. The company then changed its name to Total Renal Care Holdings, Inc. In October 1995, the company became a public company via an initial public offering, raising $107 million. By December 1996, DLJ had made a 386% return on its $10.5 million investment.
On February 27, 1998, the company acquired Renal Treatment Centers for $1.3 billion in stock. The integration went poorly and in July 1999, the CEO and CFO resigned. After tripling in value between 1995 and 1998, by July 1999, the stock price was down 71% year-to-date. In October 1999, Kent J. Thiry, then 43 years old, was named CEO.
In 2000, the company sold its non-U.S. operations. In October 2000, the company was renamed DaVita Inc. In October 2005, the company acquired Gambro Healthcare. In 2012, DaVita acquired Healthcare Partners for $4.42 billion, which was renamed DaVita Medical Group. In June 2019, the division was sold to UnitedHealth Group for $4.3 billion. In 2014, DaVita acquired Colorado Springs Health Partners, with 600 employees and 110,000 patients. In March 2016, it acquired the Everett Clinic Medical Group, a 20-site physicians practice with 315,000 patients in the Seattle area, for $385 million. In May 2017, it acquired WellHealth Quality Care.
In October 2014, the company agreed to pay $350 million to settle claims that it provided illegal kickbacks to doctors. In June 2015, the company agreed to pay $450 million to settle allegations that it unnecessarily disposed of drugs and then billed the U.S. federal government for this waste. In June 2018, a jury awarded the families of 3 of the company's patients $383 million in wrongful death claims after the patients died from cardiac arrest after undergoing treatment at DaVita centers. In October 2018, it agreed to pay $270 million to settle allegations that it violated the False Claims Act by providing inaccurate information that caused Medicare Advantage Plans to receive inflated payments. James Swoben, a whistleblower, received $10 million.
In July 2021, a federal grand jury indicted DaVita and former CEO Kent Thiry on charges of labor market collusion alleging participation in conspiracies with Surgical Care Affiliates to suppress competition for the services of certain senior-level employees. The company and Thiry were acquitted by a jury in April 2022. In October 2021, the Federal Trade Commission imposed limits on the company engaging in more mergers in Utah because of its history of buying up competitors.
In 2024, the Federal Trade Commission began investigating Davita along with Fresenius Medical Care under allegations they use illegal tactics to push smaller companies out of the market. In May 2025, the benefits fund of the United Food and Commercial Workers Local 1776 filed a proposed class-action lawsuit against DaVita and Fresenius Medical Care, a rival dialysis provider, alleging that the two companies illegally conspired to inflate treatment costs.
来源：维基百科 (英语), CC BY-SA 4.0 · 在维基百科上查看 ↗
行业板块Health Care
行业Health Care
员工78000
国家US
10年表现 收入、净利润、利润率和每股收益趋势
收入$13.64B2016-12-31 → 2025-12-31
EPS$9.842016-12-31 → 2025-12-31
自由现金流$1.31B2016-12-31 → 2025-12-31
净利率6.0%2018-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | DVA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | 14.75年均值 ≈13.0 | ≈13.0 | 23.4 | 低估 | |
| P/S (TTM) | 0.85年均值 ≈0.8 | ≈0.8 | 1.8 | 低估 | |
| 市净率 (MRQ) | -14.95年均值 ≈24.1 | ≈24.1 | · | · | |
| 股价/自由现金流 (TTM) | 7.15年均值 ≈7.2 | ≈7.2 | · | · | |
| 市现率 (TTM) | 5.25年均值 ≈4.9 | ≈4.9 | 11.3 | 低估 | |
| 市净率（有形资产） (MRQ) | -11.5 | · | · | · | |
| PEG Ratio (市盈率增长比) | ≈1.6 | · | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | DVA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | 15.2%5年均值 ≈14.3% | ≈14.3% | 9.2% | 顶尖 | |
| 息税折旧摊销前利润率 (TTM) | 20.2%5年均值 ≈20.1% | ≈20.1% | 12.7% | 顶尖 | |
| 税前利润率 (TTM) | 10.5%5年均值 ≈10.6% | ≈10.6% | 4.3% | 顶尖 | |
| 净利润率 (TTM) | 6.0%5年均值 ≈6.3% | ≈6.3% | 5.1% | 顶尖 | |
| ROA (TTM) | 4.8%5年均值 ≈4.6% | ≈4.6% | 3.7% | 顶尖 | |
| ROE (TTM) | -149.4%5年均值 ≈24.7% | ≈24.7% | 10.5% | 弱 | |
| ROIC | -245.6%5年均值 ≈325.5% | ≈325.5% | 5.1% | 弱 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | DVA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 1.55年均值 ≈1.3 | ≈1.3 | 1.5 | 持平 | |
| 速动比率 (MRQ) | 1.15年均值 ≈1.0 | ≈1.0 | 1.0 | 持平 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | DVA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 6.5%5年均值 ≈3.4% | ≈3.4% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 5.5%5年均值 ≈3.5% | ≈3.5% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | 3.4% | · | · | · | |
| EPS YoY | -8.3%5年均值 ≈14.0% | ≈14.0% | · | · | |
| Net Income YoY (净利润同比增长) | -20.2%5年均值 ≈4.5% | ≈4.5% | · | · | |
| EPS CAGR 3Y (每股收益年复合增长率（3年）) | 18.9%5年均值 ≈10.3% | ≈10.3% | · | · | |
| EPS CAGR 5Y (每股收益年复合增长率（5年）) | 9.3% | · | · | · | |
| Net Income CAGR 3Y (净利润年复合增长率（3年）) | 10.0%5年均值 ≈1.6% | ≈1.6% | · | · | |
| Net Income CAGR 5Y (净利润年复合增长率（5年）) | -0.70% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | DVA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.85年均值 ≈0.7 | ≈0.7 | 0.8 | 持平 | |
| Receivables Turnover (应收账款周转率) | 6.05年均值 ≈6.0 | ≈6.0 | 10.6 | 弱 | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$174.9K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
股息 收益率、派息率、股息历史、5年CAGR
股息收益率0.00%
派息率0.00%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
0.05%
下次报告
十月 27, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 3, 2026 | $4.02 | $3.92 | 2.5% |
| 2026年3月31日 | 五月 11, 2026 | $2.87 | $2.34 | 22.6% |
| 2025年12月31日 | $3.40 | $3.19 | 6.7% | |
| 2025年9月30日 | $2.04 | $3.25 | -37.3% | |
| 2025年6月30日 | $2.95 | $2.83 | 4.2% | |
| 2025年3月31日 | $2.00 | $1.97 | 1.7% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B | $11.55B | $11.39B | $11.40B | $10.88B | $10.71B | |
| SG&A Expense | $1.67B | $1.54B | $1.47B | $1.36B | $1.20B | $1.25B | $1.10B | $1.14B | $1.06B | $1.07B | |
| Operating Expenses | $11.60B | $10.73B | $10.54B | $10.27B | $9.82B | $9.86B | $9.75B | $9.88B | $9.06B | $8.68B | |
| Operating Income | $2.04B | $2.09B | $1.60B | $1.34B | $1.80B | $1.69B | $1.64B | $1.53B | $1.81B | $2.03B | |
| Other Non-op | $-103M | $-70M | $-19M | $-16M | $6M | $17M | $29M | $10M | $18M | $8M | |
| Pretax Income | $1.35B | $1.53B | $1.18B | $966M | $1.52B | $1.32B | $1.20B | $1.05B | $1.40B | $1.62B | |
| Income Tax | $293M | $280M | $220M | $198M | $307M | $314M | $280M | $258M | $324M | $432M | |
| Net Income | $747M | $936M | $692M | $560M | $978M | $774M | $811M | $159M | $664M | $880M | |
| EPS (Basic) | $10.06 | $11.02 | $7.62 | $6.03 | $9.30 | $6.46 | $5.29 | $0.93 | $3.52 | $4.36 | |
| EPS (Diluted) | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 | $6.31 | $5.27 | $0.92 | $3.47 | $4.29 | |
| Shares (Basic) | 74,227,000 | 84,991,000 | 90,790,000 | 92,992,000 | 105,230,000 | 119,797,000 | 153,181,000 | 170,786,000 | 188,625,559 | 201,641,173 | |
| Shares (Diluted) | 75,885,000 | 87,274,000 | 93,182,000 | 95,834,000 | 109,948,000 | 122,623,000 | 153,812,000 | 172,365,000 | 191,348,533 | 204,904,656 | |
| EBITDA | $2.75B | $2.81B | $2.34B | $2.06B | $2.47B | $2.31B | $2.24B | $2.10B | $2.36B | $2.44B |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $676M | $795M | $380M | $244M | $462M | $325M | $1.10B | $323M | $508M | $675M | |
| Short-term Investments | $24M | $51M | $12M | $78M | $22M | $20M | $12M | $3M | $33M | $307M | |
| Receivables | $2.41B | $2.15B | $1.99B | $2.13B | $1.96B | $1.82B | $1.80B | $1.86B | $1.71B | $1.50B | |
| Inventory | $161M | $135M | $143M | $109M | $107M | $112M | $98M | $107M | $182M | $160M | |
| Prepaid Expense | $156M | $123M | $103M | $79M | $73M | $76M | $67M | $112M | $112M | $100M | |
| Other Current Assets | · | · | · | · | · | · | · | · | $112M | $100M | |
| Current Assets | $4.06B | $3.75B | $3.14B | $3.16B | $3.17B | $3.15B | $3.69B | $8.42B | $8.77B | $3.99B | |
| PP&E (Net) | $2.81B | $2.94B | $3.07B | $3.26B | $3.48B | $3.52B | $3.47B | $3.39B | $3.15B | $2.86B | |
| PP&E (Gross) | $9.42B | $9.20B | $8.83B | $8.52B | $8.24B | $8.00B | $7.44B | $6.92B | $6.25B | $5.56B | |
| Accum. Depreciation | $6.60B | $6.26B | $5.76B | $5.27B | $4.76B | $4.48B | $3.97B | $3.52B | $3.10B | $2.70B | |
| Goodwill | $7.55B | $7.38B | $7.11B | $7.08B | $7.05B | $6.92B | $6.79B | $6.84B | $6.61B | $6.02B | |
| Intangibles | $222M | $197M | $203M | $183M | $178M | $167M | $136M | $119M | $114M | $74M | |
| Other Non-current Assets | $247M | $262M | $271M | $316M | $137M | $80M | $116M | $72M | $47M | $34M | |
| Total Assets | $17.48B | $17.29B | $16.89B | $16.93B | $17.12B | $16.99B | $17.31B | $19.11B | $18.97B | $18.76B | |
| Accounts Payable | $696M | $547M | $515M | $480M | $402M | $434M | $404M | $463M | $509M | $457M | |
| Current Liabilities | $3.14B | $2.97B | $2.64B | $2.62B | $2.40B | $2.48B | $2.37B | $4.89B | $3.07B | $2.71B | |
| Capital Leases | $2.18B | $2.21B | $2.33B | $2.50B | $2.67B | $2.74B | $2.72B | $0 | · | · | |
| Deferred Tax | $757M | $665M | $726M | $783M | $831M | $810M | $578M | $563M | $486M | $531M | |
| Other Non-current Liabilities | $84M | $170M | $183M | $105M | $119M | $150M | $161M | $451M | $365M | $317M | |
| Total Liabilities | $16.32B | $15.19B | $14.15B | $14.70B | $14.75B | $14.09B | $13.81B | $14.08B | $13.08B | $12.93B | |
| Common Stock | $69.0K | $90.0K | $89.0K | $90.0K | $97.0K | $110.0K | $126.0K | $166.0K | $182.0K | $195.0K | |
| Retained Earnings | $-328M | $1.53B | $598M | $174M | $354M | $853M | $1.43B | $2.74B | $3.63B | $3.71B | |
| Treasury Stock | $200M | $1.39B | $0 | · | $0 | $0 | $0 | $0 | $0 | $0 | |
| AOCI | $-123M | $-311M | $-52M | $-69M | $-139M | $-66M | $-47M | $-35M | $13M | $-90M | |
| Stockholders' Equity | $-651M | $121M | $1.06B | $712M | $756M | $1.38B | $2.13B | $3.70B | $4.69B | $4.65B | |
| Liabilities + Equity | $17.48B | $17.29B | $16.89B | $16.93B | $17.12B | $16.99B | $17.31B | $19.11B | $18.97B | $18.76B | |
| Shares Outstanding | 68,549,000 | 90,369,000 | 88,824,000 | 90,411,000 | 97,289,000 | 109,933,000 | 125,843,000 | 166,387,000 | 182,462,000 | 194,554,000 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $708M | $716M | $736M | $721M | $668M | $617M | $601M | $575M | $544M | $495M | |
| Stock-based Comp | $140M | $103M | $112M | $95M | $102M | $91M | $68M | $73M | $35M | $38M | |
| Deferred Tax | $87M | $-58M | $-39M | $-76M | $60M | $241M | $42M | $274M | $-395M | $52M | |
| Amort. of Intangibles | $7M | $7M | $9M | $11M | $13M | $14M | $14M | $16M | $16M | $15M | |
| Other Non-cash | $205M | $324M | $558M | $263M | $122M | $256M | $551M | $691M | $1.06B | $447M | |
| Operating Cash Flow | $1.89B | $2.02B | $2.06B | $1.56B | $1.93B | $1.98B | $2.07B | $1.77B | $1.91B | $1.97B | |
| CapEx | $576M | $555M | $568M | $603M | $641M | $675M | $767M | $987M | $905M | $829M | |
| Investing Cash Flow | $-655M | $-771M | $-772M | $-630M | $-785M | $-825M | $3.00B | $-1.01B | $-1.36B | $-1.20B | |
| Debt Issued | $5.61B | $6.62B | $2.47B | $2.39B | $1.62B | $4.05B | $38.53B | $59.93B | $50.99B | $51.99B | |
| Net Debt Issued | $5.61B | $6.62B | $2.47B | $2.39B | $1.62B | $4.05B | $38.53B | $59.93B | $50.99B | $51.99B | |
| Stock Repurchased | $1.31B | $1.39B | $272M | $802M | $1.54B | $1.46B | $2.38B | $1.16B | $803M | $1.10B | |
| Net Stock Activity | $-1.31B | $-1.39B | $-272M | $-802M | $-1.54B | $-1.46B | $-2.38B | $-1.16B | $-803M | $-1.10B | |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | |
| Financing Cash Flow | $-1.37B | $-817M | $-1.17B | $-1.12B | $-1.08B | $-1.85B | $-4.70B | $-625M | $-766M | $-1.35B | |
| Net Change in Cash | $-122M | $415M | $126M | $-216M | $53M | $-707M | $369M | $137M | $-218M | $-577M | |
| Taxes Paid | $177M | $388M | $268M | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.31B | $1.47B | $1.49B | $961M | $1.29B | $1.30B | $1.31B | $785M | $1.00B | $1.13B |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 15.0% | 16.3% | 13.2% | 11.5% | 15.5% | 14.7% | 14.4% | 13.4% | · | · | |
| Net Margin | 5.5% | 7.3% | 5.7% | 4.8% | 8.4% | 6.7% | 7.1% | 1.4% | · | · | |
| Pretax Margin | 9.9% | 11.9% | 9.7% | 8.3% | 13.1% | 11.4% | 10.5% | 9.2% | · | · | |
| EBITDA Margin | 20.2% | 21.9% | 19.3% | 17.8% | 21.2% | 20.0% | 19.7% | 18.4% | · | · | |
| ROA | 4.3% | 5.5% | 4.1% | 3.3% | 5.7% | 4.5% | 4.5% | 0.84% | 3.5% | 4.7% | |
| ROE | -281.8% | 159.1% | 78.2% | 76.4% | 91.5% | 44.0% | 27.8% | 3.8% | 14.2% | 18.5% | |
| ROIC | -245.6% | 1410.5% | 123.4% | 149.4% | 189.8% | 93.3% | 59.0% | 31.1% | 29.7% | 28.3% |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.3 | 1.2 | 1.2 | 1.3 | 1.3 | 1.6 | 1.7 | 2.9 | 1.5 | |
| Quick Ratio | 1.0 | 1.0 | 0.9 | 0.9 | 1.0 | 0.9 | 1.2 | 0.4 | 0.7 | 1.2 |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.6 | 0.6 | · | · | |
| Receivables Turnover | 6.0 | 6.2 | 5.9 | 5.7 | 6.1 | 6.4 | 6.2 | 6.4 | · | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-9.50 | $1.50 | $11.89 | $7.88 | $7.77 | $12.59 | $16.95 | $22.26 | $25.70 | $23.89 | |
| Revenue / Share | $179.79 | $146.84 | $130.28 | $121.15 | $105.68 | $94.20 | $74.04 | $66.17 | · | · | |
| Cash Flow / Share | $24.86 | $23.17 | $22.10 | $16.33 | $17.56 | $16.14 | $13.47 | $10.28 | $9.97 | $9.58 | |
| Cash / Share | $9.87 | $9.87 | $4.28 | $2.70 | $4.75 | $2.96 | $8.76 | $1.94 | $2.79 | $4.69 | |
| EPS (TTM) | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 | $6.31 | $5.27 | $0.92 | $3.47 | $4.29 |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 6.5% | 5.6% | 4.6% | -0.08% | 0.59% | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.5% | 3.3% | 1.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 3.4% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -8.3% | 44.6% | 26.8% | -34.3% | 41.0% | · | · | · | · | · | |
| EPS CAGR 3Y | 18.9% | 6.4% | 5.5% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 9.3% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -20.2% | 35.4% | 23.4% | -42.7% | 26.5% | · | · | · | · | · | |
| Net Income CAGR 3Y | 10.0% | -1.5% | -3.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.70% | · | · | · | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B | $11.55B | $11.39B | $11.40B | $10.88B | $10.71B | |
| Net Income TTM | $747M | $936M | $692M | $560M | $978M | $774M | $811M | $159M | $664M | $880M | |
| Market Cap | $7.79B | $12.04B | $9.31B | $6.75B | $11.07B | $12.91B | $9.44B | $8.56B | $13.18B | $12.49B | |
| P/E | 11.5 | 13.9 | 14.1 | 12.8 | 12.8 | 18.6 | 14.2 | 55.9 | 20.8 | 15.0 | |
| P/S | 0.6 | 0.9 | 0.8 | 0.6 | 1.0 | 1.1 | 0.8 | 0.8 | 1.2 | 1.2 | |
| P/B | -12.0 | 99.4 | 8.8 | 9.5 | 14.6 | 9.3 | 4.4 | 2.3 | 2.8 | 2.7 | |
| P / Cash Flow | 4.1 | 6.0 | 4.5 | 4.3 | 5.7 | 6.5 | 4.6 | 4.8 | 6.9 | 6.4 | |
| P / FCF | 5.9 | 8.2 | 6.2 | 7.0 | 8.6 | 9.9 | 7.2 | 10.9 | 13.2 | 11.0 | |
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | · | |
| Earnings Yield | 8.7% | 7.2% | 7.1% | 7.8% | 7.8% | 5.4% | 7.0% | 1.8% | 4.8% | 6.7% | |
| Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | · | · | |
| Annual Payout | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.55B | $3.42B | $3.62B | $3.42B | $3.38B | $3.22B | $3.29B | $3.26B | $3.19B | $3.07B | $3.15B | $3.12B | $3.00B | $2.87B | $2.92B | $2.95B | |
| SG&A Expense | $423M | $422M | $472M | $414M | $413M | $374M | $414M | $394M | $368M | $362M | $401M | $377M | $364M | $332M | $380M | $365M | |
| Operating Expenses | $2.98B | $2.93B | $3.06B | $2.91B | $2.84B | $2.78B | $2.73B | $2.73B | $2.68B | $2.59B | $2.76B | $2.63B | $2.60B | $2.56B | $2.66B | $2.64B | |
| Operating Income | $579M | $482M | $561M | $506M | $538M | $439M | $565M | $535M | $506M | $484M | $390M | $496M | $405M | $312M | $256M | $312M | |
| Other Non-op | $8M | $4M | $-21M | $-41M | $-23M | $-18M | $-13M | $-17M | $-27M | $-13M | $-5M | $-20M | $1M | $4M | $-8M | $-5M | |
| Pretax Income | $435M | $341M | $383M | $309M | $369M | $286M | $414M | $373M | $371M | $372M | $289M | $378M | $295M | $215M | $147M | $207M | |
| Income Tax | $92M | $66M | $77M | $69M | $94M | $54M | $64M | $78M | $72M | $66M | $58M | $69M | $49M | $44M | $34M | $43M | |
| Net Income | $265M | $198M | $234M | $150M | $199M | $163M | $259M | $215M | $223M | $240M | $151M | $247M | $179M | $116M | $68M | $105M | |
| EPS (Basic) | $4.10 | $2.93 | $3.30 | $2.09 | $2.62 | $2.05 | $3.17 | $2.56 | $2.56 | $2.73 | $1.68 | $2.70 | $1.96 | $1.28 | $0.81 | $1.16 | |
| EPS (Diluted) | $4.02 | $2.87 | $3.22 | $2.04 | $2.58 | $2.00 | $3.08 | $2.50 | $2.50 | $2.65 | $1.64 | $2.62 | $1.91 | $1.25 | $0.81 | $1.13 | |
| Shares (Basic) | 64,781,000 | 67,390,000 | · | 72,075,000 | 75,943,000 | 79,368,000 | · | 83,721,000 | 86,899,000 | 87,775,000 | · | 91,322,000 | 90,984,000 | 90,497,000 | · | 91,160,000 | |
| Shares (Diluted) | 66,092,000 | 68,875,000 | · | 73,769,000 | 77,362,000 | 81,275,000 | · | 85,795,000 | 88,950,000 | 90,547,000 | · | 94,041,000 | 93,418,000 | 92,483,000 | · | 93,263,000 | |
| EBITDA | $579M | $660M | · | $506M | $538M | $615M | · | $535M | $506M | $671M | · | $496M | $405M | $490M | · | $312M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $669M | $644M | $676M | $706M | $708M | $439M | $795M | $1.07B | $416M | $345M | · | $449M | $327M | $317M | · | $368M | |
| Short-term Investments | $20M | $22M | $24M | $31M | $31M | $73M | $51M | $21M | $21M | $11M | · | $12M | $12M | $50M | · | $74M | |
| Receivables | $2.47B | $2.46B | $2.41B | $2.33B | $2.44B | $2.32B | $2.15B | $2.27B | $2.30B | $2.59B | · | $2.02B | $2.01B | $2.06B | · | $2.09B | |
| Inventory | $152M | $142M | $161M | $139M | $146M | $151M | $135M | $129M | $127M | $146M | · | $110M | $110M | $107M | · | $107M | |
| Prepaid Expense | $149M | $160M | $156M | $161M | $110M | $130M | $123M | $97M | $83M | $105M | · | $91M | $90M | $89M | · | $66M | |
| Current Assets | $4.19B | $4.06B | $4.06B | $4.11B | $4.09B | $3.64B | $3.75B | $4.04B | $3.47B | $3.68B | · | $3.14B | $3.00B | $3.04B | · | $3.20B | |
| PP&E (Net) | $2.75B | $2.75B | $2.81B | $2.85B | $2.85B | $2.90B | $2.94B | $2.94B | $2.98B | $3.03B | · | $3.10B | $3.16B | $3.22B | · | $3.24B | |
| PP&E (Gross) | · | · | $9.42B | · | · | · | $9.20B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $6.87B | · | $6.60B | · | · | · | $6.26B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $7.59B | $7.58B | $7.55B | $7.54B | $7.47B | $7.42B | $7.38B | $7.23B | $7.20B | $7.23B | $7.11B | $7.09B | $7.11B | $7.09B | $7.08B | $7.02B | |
| Intangibles | $229M | $229M | $222M | $220M | $212M | $205M | $197M | $198M | $191M | $201M | · | $185M | $192M | $187M | · | $180M | |
| Other Non-current Assets | $299M | $267M | $247M | $204M | $193M | $239M | $262M | $219M | $240M | $262M | · | $302M | $314M | $291M | · | $308M | |
| Total Assets | $17.71B | $17.50B | $17.48B | $17.56B | $17.49B | $17.12B | $17.29B | $17.50B | $17.03B | $17.43B | · | $16.93B | $16.96B | $16.73B | · | $16.96B | |
| Accounts Payable | $716M | $691M | $696M | $656M | $594M | $596M | $547M | $488M | $494M | $490M | · | $435M | $428M | $448M | · | $417M | |
| Current Liabilities | $2.86B | $2.87B | $3.14B | $3.02B | $2.93B | $2.91B | $2.97B | $2.94B | $2.99B | $2.58B | · | $2.54B | $2.40B | $2.57B | · | $2.54B | |
| Capital Leases | $2.19B | $2.16B | $2.18B | $2.10B | $2.12B | $2.16B | $2.21B | $2.24B | $2.28B | $2.31B | · | $2.34B | $2.38B | $2.46B | · | $2.56B | |
| Deferred Tax | $826M | $819M | $757M | $742M | $646M | $665M | $665M | $660M | $694M | $720M | · | $754M | $760M | $771M | · | $819M | |
| Other Non-current Liabilities | $99M | $89M | $84M | $172M | $156M | $167M | $170M | $183M | $179M | $180M | · | $185M | $183M | $100M | · | $107M | |
| Total Liabilities | $16.63B | $16.45B | $16.32B | $16.22B | $15.94B | $15.46B | $15.19B | $15.28B | $14.60B | $14.79B | · | $14.10B | $14.33B | $14.31B | · | $14.89B | |
| Common Stock | $69.0K | $69.0K | $69.0K | $91.0K | $91.0K | $91.0K | $90.0K | $90.0K | $90.0K | $90.0K | · | $91.0K | $91.0K | $91.0K | · | $98.0K | |
| Retained Earnings | $81M | $-179M | $-328M | $2.05B | $1.90B | $1.70B | $1.53B | $1.28B | $1.06B | $838M | · | $715M | $469M | $290M | · | $847M | |
| Treasury Stock | $788M | $489M | $200M | $2.90B | $2.49B | $2.04B | $1.39B | $1.02B | $616M | $240M | · | · | · | · | · | $788M | |
| AOCI | $-59M | $-87M | $-123M | $-116M | $-138M | $-227M | $-311M | $-162M | $-195M | $-100M | · | $-69M | $-7M | $-55M | · | $-136M | |
| Stockholders' Equity | $-765M | $-755M | $-651M | $-572M | $-370M | $-267M | $121M | $387M | $633M | $926M | · | $1.20B | $1.02B | $825M | · | $533M | |
| Liabilities + Equity | $17.71B | $17.50B | $17.48B | $17.56B | $17.49B | $17.12B | $17.29B | $17.50B | $17.03B | $17.43B | · | $16.93B | $16.96B | $16.73B | · | $16.96B | |
| Shares Outstanding | 63,955,000 | 69,190,000 | 68,549,000 | 70,977,000 | 74,217,000 | 77,277,000 | 80,536,000 | 82,624,000 | 85,081,000 | 89,822,000 | 88,824,000 | 91,348,000 | 91,271,000 | 90,650,000 | 90,411,000 | 90,104,000 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $168M | $178M | $180M | $177M | $175M | $176M | $167M | $187M | $176M | $187M | $186M | $188M | $184M | $178M | $183M | $194M | |
| Stock-based Comp | $26M | $28M | $38M | $39M | $33M | $30M | $27M | $27M | $24M | $25M | $30M | $27M | $30M | $25M | $18M | $28M | |
| Deferred Tax | $-1M | $55M | $18M | $79M | $-14M | $4M | $-4M | $-25M | $-25M | $-3M | $-22M | $-2M | $-13M | $-4M | $-40M | $-45M | |
| Other Non-cash | · | $-137M | · | · | · | $-193M | · | · | · | $-583M | · | · | · | $147M | · | · | |
| Operating Cash Flow | $490M | $321M | $541M | $842M | $324M | $180M | $548M | $810M | $799M | $-135M | $485M | $661M | $450M | $463M | $344M | $711M | |
| CapEx | $170M | $102M | $145M | $166M | $121M | $143M | $171M | $139M | $125M | $121M | $159M | $137M | $124M | $148M | $194M | $144M | |
| Investing Cash Flow | $-194M | $-139M | $-163M | $-263M | $-67M | $-162M | $-248M | $-146M | $-162M | $-215M | $-168M | $-140M | $-347M | $-117M | $-213M | $-154M | |
| Debt Issued | $1.51B | $1.26B | $940M | $482M | $3.56B | $633M | $676.0K | $3.35B | $1.99B | $1.29B | $6.0K | $331M | $1.53B | $612M | $687M | $523M | |
| Net Debt Issued | · | $1.26B | · | · | · | $633M | · | · | · | $1.29B | · | · | · | $612M | · | · | |
| Stock Repurchased | $181M | $196M | $274M | $240M | $284M | $510M | $365M | $408M | $362M | $251M | $272M | $0 | $0 | $0 | $0 | $185M | |
| Net Stock Activity | · | $-196M | · | · | · | $-510M | · | · | · | $-251M | · | · | · | $0 | · | · | |
| Financing Cash Flow | $-270M | $-213M | $-415M | $-582M | $4M | $-383M | $-565M | $-8M | $-563M | $319M | $-403M | $-395M | $-97M | $-276M | $-231M | $-445M | |
| Net Change in Cash | $25M | $-31M | $-38M | $-2M | $272M | $-355M | $-279M | $655M | $72M | $-34M | $-80M | $123M | $11M | $72M | $-123M | $106M | |
| Free Cash Flow | · | $219M | · | · | · | $37M | · | · | · | $-256M | · | · | · | $315M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 16.3% | 14.1% | · | 14.8% | 15.9% | 13.6% | · | 16.4% | 15.9% | 15.8% | · | 15.9% | 13.5% | 10.8% | · | 10.6% | |
| Net Margin | 7.5% | 5.8% | · | 4.4% | 5.9% | 5.1% | · | 6.6% | 7.0% | 7.8% | · | 7.9% | 6.0% | 4.0% | · | 3.6% | |
| Pretax Margin | 12.2% | 10.0% | · | 9.0% | 10.9% | 8.9% | · | 11.4% | 11.7% | 12.1% | · | 12.1% | 9.8% | 7.5% | · | 7.0% | |
| EBITDA Margin | 16.3% | 19.3% | · | 14.8% | 15.9% | 19.1% | · | 16.4% | 15.9% | 21.9% | · | 15.9% | 13.5% | 17.1% | · | 10.6% | |
| ROA | 1.5% | 1.1% | · | 0.86% | 1.1% | 0.94% | · | 1.2% | 1.3% | 1.4% | · | 1.5% | 1.1% | 0.68% | · | 0.61% | |
| ROE | -46.8% | -38.6% | · | -162.4% | 151.4% | 49.5% | · | 27.1% | 27.0% | 27.4% | · | 28.5% | 22.0% | 13.8% | · | 12.5% | |
| ROIC | -59.7% | -51.4% | · | -68.8% | -108.5% | -133.3% | · | 109.5% | 64.6% | 43.0% | · | 33.8% | 33.2% | 30.0% | · | 46.5% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.4 | · | 1.4 | 1.4 | 1.3 | · | 1.4 | 1.2 | 1.4 | · | 1.2 | 1.2 | 1.2 | · | 1.3 | |
| Quick Ratio | 1.1 | 1.1 | · | 1.0 | 1.1 | 1.0 | · | 1.1 | 0.9 | 1.1 | · | 1.0 | 1.0 | 0.9 | · | 1.0 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 1.4 | 1.4 | · | 1.5 | 1.4 | 1.3 | · | 1.5 | 1.5 | 1.3 | · | 1.5 | 1.5 | 1.4 | · | 1.4 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-11.96 | $-10.92 | · | $-8.06 | $-4.98 | $-3.46 | · | $4.68 | $7.44 | $10.31 | · | $13.13 | $11.15 | $9.11 | · | $5.91 | |
| Revenue / Share | $53.77 | $49.59 | · | $46.36 | $43.68 | $39.66 | · | $38.04 | $35.83 | $33.91 | · | $33.19 | $32.12 | $31.06 | · | $31.62 | |
| Cash Flow / Share | · | $4.66 | · | · | · | $2.21 | · | · | · | $-1.49 | · | · | · | $5.00 | · | · | |
| Cash / Share | $10.46 | $9.31 | · | $9.95 | $9.55 | $5.68 | · | $12.96 | $4.90 | $3.84 | · | $4.92 | $3.59 | $3.50 | · | $4.08 | |
| EPS (TTM) | $12.15 | $10.71 | · | $9.70 | $10.16 | $10.08 | · | $9.29 | $9.41 | $8.82 | · | $6.59 | $5.10 | $5.49 | · | $6.85 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $14.01B | $13.84B | · | $13.32B | $13.16B | $12.97B | · | $12.67B | $12.52B | $12.34B | · | $11.91B | $11.74B | $11.67B | · | $11.64B | |
| Net Income TTM | $847M | $781M | · | $772M | $836M | $860M | · | $828M | $860M | $816M | · | $609M | $468M | $514M | · | $680M | |
| Market Cap | $14.23B | $10.63B | · | $9.43B | $10.57B | $11.82B | · | $13.54B | $11.79B | $12.40B | · | $8.64B | $9.17B | $7.35B | · | $7.46B | |
| P/E | 18.3 | 14.4 | · | 13.7 | 14.0 | 15.2 | · | 17.6 | 14.7 | 15.7 | · | 14.3 | 19.7 | 14.8 | · | 12.1 | |
| P/S | 1.0 | 0.8 | · | 0.7 | 0.8 | 0.9 | · | 1.1 | 0.9 | 1.0 | · | 0.7 | 0.8 | 0.6 | · | 0.6 | |
| P/B | -18.6 | -14.1 | · | -16.5 | -28.6 | -44.3 | · | 35.0 | 18.6 | 13.4 | · | 7.2 | 9.0 | 8.9 | · | 14.0 | |
| P / Cash Flow | · | 33.1 | · | · | · | 65.7 | · | · | · | -92.0 | · | · | · | 15.9 | · | · | |
| Earnings Yield | 5.5% | 7.0% | · | 7.3% | 7.1% | 6.6% | · | 5.7% | 6.8% | 6.4% | · | 7.0% | 5.1% | 6.8% | · | 8.3% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B |
| 营业利润率 % | 15.0% | 16.3% | 13.2% | 11.5% | 15.5% |
| 净收入 | $747M | $936M | $692M | $560M | $978M |
| 稀释后每股收益 (EPS) | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 1.3 | 1.3 | 1.2 | 1.2 | 1.3 |
| 速动比率 | 1.0 | 1.0 | 0.9 | 0.9 | 1.0 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $1.31B | $1.47B | $1.49B | $961M | $1.29B |
机构持有人 (13F) 692 家申报者 · $13.6B 总计 · 截至 2026年9月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
692
持有价值
$13.6B
新仓位
126
已退出持仓
61
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 126 (-14 与上一季度对比) | 61 (-2 与上一季度对比) | 195 (+23 与上一季度对比) | 226 (+12 与上一季度对比) | -1.1M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| Berkshire Hathaway Inc | $6425268898 | 28880209 | 47.23% | 股份 |
| BlackRock, Inc. | $547520494 | 2460987 | 4.02% | 股份 |
| VANGUARD GROUP INC | $471976159 | 4154354 | 3.47% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $467525034 | 2101425 | 3.44% | 股份 |
| MORGAN STANLEY | $356348822 | 1601710 | 2.62% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $306558307 | 1377914 | 2.25% | 股份 |
| STATE STREET CORP | $294345267 | 1323019 | 2.16% | 股份 |
| Invesco Ltd. | $269627293 | 1211917 | 1.98% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $253130449 | 1137814 | 1.86% | 股份 |
| NEUBERGER BERMAN GROUP LLC | $205758498 | 925579 | 1.51% | 股份 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $197802963 | 889082 | 1.45% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $189562167 | 853602 | 1.39% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $163166832 | 733400 | 1.20% | 买入期权 |
| Gates Capital Management, Inc. | $153096497 | 688136 | 1.13% | 股份 |
| BANK OF AMERICA CORP /DE/ | $145056737 | 651999 | 1.07% | 股份 |
| D. E. Shaw & Co., Inc. | $142571191 | 640827 | 1.05% | 股份 |
| AQR CAPITAL MANAGEMENT LLC | $128131338 | 587758 | 0.94% | 股份 |
| GOLDMAN SACHS GROUP INC | $103093004 | 463381 | 0.76% | 股份 |
| Bank of New York Mellon Corp | $101127189 | 454545 | 0.74% | 股份 |
| NORDEA INVESTMENT MANAGEMENT AB | $87427043 | 395687 | 0.64% | 股份 |
| NORTHERN TRUST CORP | $84995593 | 382037 | 0.62% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $81331791 | 365569 | 0.60% | 股份 |
| NORGES BANK | $76627007 | 344422 | 0.56% | 股份 |
| UBS Group AG | $67900673 | 305199 | 0.50% | 股份 |
| JANE STREET GROUP, LLC | $62548028 | 281140 | 0.46% | 股份 |
| JANE STREET GROUP, LLC | $53573184 | 240800 | 0.39% | 买入期权 |
| Holocene Advisors, LP | $52875709 | 237665 | 0.39% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $48100176 | 216200 | 0.35% | 卖出期权 |
| ROYAL BANK OF CANADA | $47787000 | 214787 | 0.35% | 股份 |
| DEUTSCHE BANK AG\ | $46356378 | 208362 | 0.34% | 股份 |
| Quantinno Capital Management LP | $45366106 | 203910 | 0.33% | 股份 |
| JPMORGAN CHASE & CO | $44467785 | 200781 | 0.33% | 股份 |
| CITADEL ADVISORS LLC | $44465298 | 199862 | 0.33% | 股份 |
| CITADEL ADVISORS LLC | $44184528 | 198600 | 0.32% | 买入期权 |
| BARCLAYS PLC | $43410740 | 195122 | 0.32% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $40134502 | 180396 | 0.30% | 股份 |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $37089700 | 241328 | 0.27% | 股份 |
| Gotham Asset Management, LLC | $36393278 | 163580 | 0.27% | 股份 |
| JANE STREET GROUP, LLC | $35774784 | 160800 | 0.26% | 卖出期权 |
| Doma Perpetual Capital Management LLC | $35522937 | 159668 | 0.26% | 股份 |
| FIRST TRUST ADVISORS LP | $34161205 | 153548 | 0.25% | 股份 |
| TODD ASSET MANAGEMENT LLC | $32697663 | 146969 | 0.24% | 股份 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $32011312 | 143884 | 0.24% | 股份 |
| Allianz Asset Management GmbH | $30236367 | 135906 | 0.22% | 股份 |
| Toroso Investments, LLC | $29297520 | 257878 | 0.22% | 股份 |
| CANADA PENSION PLAN INVESTMENT BOARD | $26480460 | 119024 | 0.19% | 股份 |
| VICTORY CAPITAL MANAGEMENT INC | $26377896 | 118563 | 0.19% | 股份 |
| Amundi | $25967198 | 116717 | 0.19% | 股份 |
| FMR LLC | $25475535 | 114507 | 0.19% | 股份 |
| Davidson Kempner Capital Management LP | $25162043 | 113098 | 0.18% | 股份 |
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Warren E. Buffett, Berkshire Hathaway Inc., National Indemnity Company, GEICO Corporation, Government Employees Insurance Company, Berkshire Hathaway Consolidated Pension Plan Master Trust, BNSF Master Retirement Trust, Scott Fetzer Company Collective Investment Trust, R. Ted Weschler ×13 申报 | 2025年2月13日 | 45.00% | 修订 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 59 位内幕人士 · 31 位高管 · 25 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Javier Rodriguez | Chief Executive Officer | 2026年6月16日 S | 840408 | 0 | 2 | $-14532097 |
| Dennis Kogod | Pres, HCP & CEO, DVA Int. | 2016年5月17日 S | 18766 | 0 | 0 | $0 |
| Joel Ackerman | CFO and Treasurer | 2026年5月7日 S | 132434 | 0 | 1 | $-9887579 |
| Luis Borgen | Chief Financial Officer | 2012年3月22日 M | 18517 | 0 | 0 | $0 |
| Richard K Whitney | Chief Financial Officer | 2010年3月31日 A | 33604 | 0 | 0 | $0 |
| Mark G Harrison | Chief Financial Officer | 2007年3月14日 A | 31250 | 0 | 0 | $0 |
| Gary Beil | Acting Chief Financial Officer | 2006年7月1日 A | 10000 | 0 | 0 | $0 |
| David Paul Maughan | Chief Operating Officer, DKC | 2026年9月22日 F | 86604 | 0 | 2 | $-4089696 |
| Michael David Staffieri | Chief Operating Officer, DKC | 2024年8月16日 S | 209365 | 0 | 0 | $0 |
| Joseph C Mello | COO, HCP | 2016年12月24日 A | 4688 | 0 | 0 | $0 |
| Kathleen Alyce Waters | Chief Legal & Pub. Affairs Off | 2026年6月15日 S | 109194 | 0 | 2 | $-3210360 |
| James O Hearty | Chief Compliance Officer | 2026年5月14日 M | 22389 | 0 | 2 | $-3291616 |
| Christopher Michael Berry | Chief Accounting Officer | 2026年3月15日 A | 19640 | 0 | 0 | $0 |
| John D Winstel | Chief Accounting Officer | 2023年3月15日 F | 15676 | 0 | 0 | $0 |
| Leanne M Zumwalt | Group VP, Government Affairs | 2020年9月18日 M | 24590 | 0 | 0 | $0 |
| Kent J Thiry | Executive Chairman | 2020年6月1日 F | 110462 | 0 | 0 | $0 |
| James K Hilger | Chief Accounting Officer | 2019年6月2日 F | 33125 | 0 | 0 | $0 |
| Jeanine Marie Jiganti | Chief Compliance Officer | 2017年6月13日 M | 3514 | 0 | 0 | $0 |
| Kim M Rivera | Chief Legal Officer | 2015年9月22日 M | 7438 | 0 | 0 | $0 |
| Robert J Margolis | Co-Chairman of the Board | 2015年6月4日 S | 2322928 | 0 | 0 | $0 |
| Allen Nissenson | Chief Medical Officer | 2014年2月13日 M | 8990 | 0 | 0 | $0 |
| Garry E Menzel | Senior Vice President, Finance | 2013年9月9日 A | · | 0 | 0 | $0 |
| David T Shapiro | Chief Special Counsel | 2013年8月2日 G | 2315 | 0 | 0 | $0 |
| Thomas O Usilton | Senior Vice President | 2012年2月29日 M | 17491 | 0 | 0 | $0 |
| Georgina Randolph | Senior Vice President | 2009年6月17日 M | 5547 | 0 | 0 | $0 |
| Joseph Schohl | VP, Gen. Counsel & Secretary | 2009年2月13日 M | 2084 | 0 | 0 | $0 |
| Christopher J Riopelle | Chief Compliance Officer | 2008年8月11日 M | 2500 | 0 | 0 | $0 |
| Mary Kowenhoven | Vice President - Strategy | 2008年3月5日 A | · | 0 | 0 | $0 |
| Patricia Jones | Chief People Officer | 2007年7月16日 A | 6250 | 0 | 0 | $0 |
| Charles J Mcallister | Chief Medical Officer | 2007年5月8日 M | 999 | 0 | 0 | $0 |
| Thomas L Kelly | Executive Vice President | 2005年11月4日 M | 42000 | 0 | 0 | $0 |
| Dennis W Pullin | 董事 | 2026年8月15日 A | 2949 | 0 | 0 | $0 |
| Gregory J. Moore | 董事 | 2026年8月15日 A | 8091 | 0 | 0 | $0 |
| Jason M. Hollar | 董事 | 2026年8月15日 A | 6883 | 0 | 0 | $0 |
| Patricia M Arway | 董事 | 2026年8月15日 A | 27223 | 0 | 0 | $0 |
| Adam H Schechter | 董事 | 2026年8月15日 A | 5970 | 0 | 0 | $0 |
| Wendy Lee Schoppert | 董事 | 2026年8月15日 A | 278 | 0 | 0 | $0 |
| Phyllis R Yale | 董事 | 2026年8月15日 A | 9803 | 0 | 0 | $0 |
| Barbara J Desoer | 董事 | 2026年8月15日 A | 278 | 0 | 0 | $0 |
| Charles Berg | 董事 | 2025年5月15日 A | 19982 | 0 | 0 | $0 |
| John M Nehra | 董事 | 2024年5月15日 A | 363 | 0 | 0 | $0 |
| Paul J Diaz | 董事 | 2023年5月15日 A | 16069 | 0 | 0 | $0 |
| Paula A Price | 董事 | 2022年5月15日 A | 1395 | 0 | 0 | $0 |
| Shawn M Guertin | 董事 | 2021年5月15日 A | 1105 | 0 | 0 | $0 |
| Pascal Desroches | 董事 | 2020年11月15日 A | 8030 | 0 | 0 | $0 |
| William L Roper | 董事 | 2020年6月11日 A | 16234 | 0 | 0 | $0 |
| Peter T Grauer | 董事 | 2020年6月11日 A | 76204 | 0 | 0 | $0 |
| Carol Anthony Davidson | 董事 | 2017年12月31日 A | 10764 | 0 | 0 | $0 |
| Willard Woodson Brittain JR | 董事 | 2012年6月11日 A | 7195 | 0 | 0 | $0 |
| Richard C Vaughan | 董事 | 2010年5月13日 A | 6092 | 0 | 0 | $0 |
| Nancy Ann Deparle | 董事 | 2008年6月30日 A | 3256 | 0 | 0 | $0 |
| Raymond C Larkin JR | 董事 | 2007年3月31日 A | 8684 | 0 | 0 | $0 |
| Michele J Hooper | 董事 | 2005年5月13日 A | 680 | 0 | 0 | $0 |
| R. Ted Weschler | · | 2020年9月17日 S | 1991806 | 0 | 0 | $0 |
| Roger Valine | · | 2017年6月30日 A | 306 | 0 | 0 | $0 |
| Laura Mildenberger | · | 2015年12月17日 M | 8447 | 0 | 0 | $0 |
| Richard B Fontaine | · | 2007年5月16日 G | 10000 | 0 | 0 | $0 |
| Lori Richardson Pelliccioni | · | 2005年2月25日 M | 3000 | 0 | 0 | $0 |
| Patrick A Broderick | · | 2004年5月5日 M | 0 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 97 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| OMAH · Tidal Trust III | 5.19% | 213947 NS | 2026年7月31日 | N-PORT |
| STNC · Hennessy Funds Trust | 3.36% | 13006 NS | 2026年7月31日 | N-PORT |
| AZTD · Tidal Trust I | 3.06% | 4824 NS | 2026年7月31日 | N-PORT |
| FXH · First Trust Exchange-Traded Alpha... | 2.44% | 106663 NS | 2026年7月31日 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.59% | 78593 SH | 2026年10月2日 | 每日 |
| AMOM · Exchange Listed Funds Trust | 1.41% | 1399 NS | 2026年7月31日 | N-PORT |
| LSEQ · Harbor ETF Trust | 1.19% | 760 NS | 2026年7月31日 | N-PORT |
| IHF · iShares Trust | 0.85% | 61700 SH | 2026年9月11日 | 每日 |
| JMID · Janus Detroit Street Trust | 0.46% | 456 NS | 2026年7月31日 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund ... | 0.46% | 8917 NS | 2026年7月31日 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0.34% | 4688 NS | 2026年7月31日 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund ... | 0.34% | 6488 NS | 2026年7月31日 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0.31% | 9914 SH | 2026年8月19日 | 每日 |
| ROSC · Lattice Strategies Trust | 0.27% | 691 NS | 2026年7月31日 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0.24% | 22513 SH | 2026年10月2日 | 每日 |
| BKMC · BNY Mellon ETF Trust | 0.22% | 5948 NS | 2026年7月31日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.20% | 126925 NS | 2026年7月31日 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0.20% | 1066571 SH | 2026年10月2日 | 每日 |
| BBMC · J.P. Morgan Exchange-Traded Fund ... | 0.18% | 15260 NS | 2026年7月31日 | N-PORT |
| FNK · First Trust Exchange-Traded Alpha... | 0.15% | 1456 NS | 2026年7月31日 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0.15% | 467367 SH | 2026年8月19日 | 每日 |
| FHLC · FIDELITY COVINGTON TRUST | 0.12% | 15871 NS | 2026年7月31日 | N-PORT |
| ISCG · iShares Trust | 0.12% | 6102 SH | 2026年9月11日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.11% | 100394 SH | 2026年8月19日 | 每日 |
| ESML · iShares Trust | 0.10% | 16178 SH | 2026年9月11日 | 每日 |
| IYH · iShares Trust | 0.09% | 18805 SH | 2026年9月11日 | 每日 |
| EQAL · Invesco Exchange-Traded Fund Trus... | 0.09% | 4169 SH | 2026年10月2日 | 每日 |
| VB · VANGUARD INDEX FUNDS | 0.09% | 736199 SH | 2026年8月19日 | 每日 |
| CURE · Direxion Shares ETF Trust | 0.09% | 632 NS | 2026年7月31日 | N-PORT |
| SMMD · iShares Trust | 0.08% | 17274 SH | 2026年9月11日 | 每日 |
| FNX · First Trust Exchange-Traded Alpha... | 0.08% | 4629 NS | 2026年7月31日 | N-PORT |
| TILT · FlexShares Trust | 0.08% | 7288 NS | 2026年7月31日 | N-PORT |
| IXJ · iShares Trust | 0.07% | 16934 SH | 2026年9月11日 | 每日 |
| RWL · Invesco Exchange-Traded Fund Trus... | 0.07% | 38130 SH | 2026年10月2日 | 每日 |
| DFAC · Dimensional ETF Trust | 0.06% | 121442 NS | 2026年7月31日 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Inde... | 0.06% | 3250 SH | 2026年10月2日 | 每日 |
| DUHP · Dimensional ETF Trust | 0.06% | 29605 NS | 2026年7月31日 | N-PORT |
| WSML · iShares Trust | 0.05% | 2005 SH | 2026年9月10日 | 每日 |
| IWS · iShares Trust | 0.05% | 45297 SH | 2026年9月11日 | 每日 |
| FAB · First Trust Exchange-Traded Alpha... | 0.05% | 322 NS | 2026年7月31日 | N-PORT |
| IWR · iShares Trust | 0.04% | 131978 SH | 2026年9月11日 | 每日 |
| DCOR · Dimensional ETF Trust | 0.04% | 5974 NS | 2026年7月31日 | N-PORT |
| CATH · Global X Funds | 0.04% | 1967 NS | 2026年7月31日 | N-PORT |
| XOEF · iShares Trust | 0.04% | 43 SH | 2026年9月10日 | 每日 |
| PRF · Invesco Exchange-Traded Fund Trust | 0.03% | 15586 SH | 2026年10月2日 | 每日 |
| SPMO · Invesco Exchange-Traded Fund Trus... | 0.03% | 34460 SH | 2026年10月2日 | 每日 |
| DFAU · Dimensional ETF Trust | 0.03% | 13203 NS | 2026年7月31日 | N-PORT |
| CHRI · Global X Funds | 0.02% | 8 NS | 2026年7月31日 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.02% | 2124 NS | 2026年7月31日 | N-PORT |
| EGLE · Global X Funds | 0.02% | 2 NS | 2026年7月31日 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0.02% | 7420 SH | 2026年8月19日 | 每日 |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 18428 SH | 2026年8月19日 | 每日 |
| IVE · iShares Trust | 0.02% | 53283 SH | 2026年9月11日 | 每日 |
| IUSV · iShares Trust | 0.02% | 27948 SH | 2026年9月11日 | 每日 |
| NEAR · iShares U.S. ETF Trust | 0.02% | 949000 SH | 2026年9月9日 | 每日 |
| DSI · iShares Trust | 0.02% | 4810 SH | 2026年9月11日 | 每日 |
| IWD · iShares Trust | 0.01% | 67699 SH | 2026年9月11日 | 每日 |
| XRMI · Global X Funds | 0.01% | 30 NS | 2026年7月31日 | N-PORT |
| XYLD · Global X Funds | 0.01% | 1746 NS | 2026年7月31日 | N-PORT |
| PTLC · Pacer Funds Trust | 0.01% | 1706 NS | 2026年7月31日 | N-PORT |
| DYNF · BlackRock ETF Trust | 0.01% | 27844 SH | 2026年9月11日 | 每日 |
| XYLG · Global X Funds | 0.01% | 32 NS | 2026年7月31日 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0.01% | 121 NS | 2026年7月31日 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.01% | 9492 NS | 2026年7月31日 | N-PORT |
| QDPL · Pacer Funds Trust | 0.01% | 766 NS | 2026年7月31日 | N-PORT |
| TOPC · iShares Trust | 0.01% | 19 SH | 2026年9月10日 | 每日 |
| XVV · iShares Trust | 0.01% | 377 SH | 2026年9月10日 | 每日 |
| VOO · VANGUARD INDEX FUNDS | 0.01% | 832243 SH | 2026年8月19日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.01% | 1019458 SH | 2026年8月19日 | 每日 |
| VT · VANGUARD INTERNATIONAL EQUITY IND... | 0.01% | 28136 SH | 2026年8月19日 | 每日 |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.01% | 5315 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.01% | 2714 SH | 2026年8月19日 | 每日 |
| ESGV · VANGUARD WORLD FUND | 0.01% | 7283 SH | 2026年8月19日 | 每日 |
| XTR · Global X Funds | 0.01% | 2 NS | 2026年7月31日 | N-PORT |
| HCMT · Direxion Shares ETF Trust | 0.01% | 225 NS | 2026年7月31日 | N-PORT |
| IWP · iShares Trust | 0.01% | 9703 SH | 2026年9月11日 | 每日 |
| PBP · Invesco Exchange-Traded Fund Trust | 0.01% | 203 SH | 2026年9月30日 | 每日 |
| SPXL · Direxion Shares ETF Trust | 0.01% | 2512 NS | 2026年7月31日 | N-PORT |
| IVV · iShares Trust | 0.01% | 404382 SH | 2026年9月11日 | 每日 |
| IWB · iShares Trust | 0.01% | 22249 SH | 2026年9月11日 | 每日 |
| IYY · iShares Trust | 0.01% | 1374 SH | 2026年9月10日 | 每日 |
| IWV · iShares Trust | 0.01% | 8841 SH | 2026年9月10日 | 每日 |
| ITOT · iShares Trust | 0.01% | 41624 SH | 2026年9月11日 | 每日 |
| PHDG · Invesco Actively Managed Exchange... | 0.01% | 24 SH | 2026年9月30日 | 每日 |
| XCLR · Global X Funds | 0.01% | 1 NS | 2026年7月31日 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Inde... | 0.01% | 1542 SH | 2026年10月2日 | 每日 |
| IWF · iShares Trust | 0.00% | 6443 SH | 2026年9月2日 | 每日 |
| GTO · Invesco Actively Managed Exchange... | 0.00% | 7000 | 2026年9月30日 | 每日 |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0.00% | 2838 SH | 2026年8月19日 | 每日 |
| VGHY · VANGUARD FIXED INCOME SECURITIES ... | · | · | 2026年7月15日 | 每日 |
| VCRB · VANGUARD MALVERN FUNDS | · | · | 2026年7月15日 | 每日 |
| VPLS · VANGUARD MALVERN FUNDS | · | · | 2026年7月15日 | 每日 |
| VGMS · VANGUARD MALVERN FUNDS | · | · | 2026年7月15日 | 每日 |
| ISCB · iShares Trust | · | 1571 SH | 2026年9月11日 | 每日 |
| ISCV · iShares Trust | · | 3661 SH | 2026年9月11日 | 每日 |
| SMLF · iShares Trust | · | 5973 SH | 2026年9月11日 | 每日 |
| SMMV · iShares Trust | · | 1837 SH | 2026年9月1日 | 每日 |
DVA 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 13 位分析师
买入
中位数目标
$220.00
+23.1%
1 7.7%
强烈买入
6 46.2%
买入
5 38.5%
持有
1 7.7%
卖出
0 0.0%
强烈卖出
12个月价格目标
7 位分析师 · 2026-10-04平均目标 $219.86 +23.0%
现在
当前价格 $178.69
最低$165.00
平均值$219.86
最高$270.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | · |
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | · |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | · |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| HIMS | · | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
| CHE | · | 23.3 | 4.1% | 10.5% | 24.4% | · |
| RDNT | $5.28B | -285.4 | 11.5% | -0.91% | -1.9% | · |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | · |
交易信号 近期买入/卖出信号，包含入场价和风险/回报比
BLUECHIP_DIP
止损出局
风险 1
奖励 2.08
入场
$179.50
R:R 2.08
BLUECHIP_DIP
已过期
风险 1
奖励 2.08
入场
$176.69
R:R 2.08
目前没有公开信号 — 没有卡片被填写，这是诚实的。
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 4, 2026 申报